Specialty
General & Plastic Surgery devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
4,227
510(k), De Novo and PMA
Decisions, last 36 months
1,122
Recruiting device trials
205
Industry sponsored
Adverse event reports
126,787
Received Nov 1, 2025 to Nov 19, 2026
Narrower views
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
K262232 · Decided Nov 6, 2026 · 129 days after receipt
Device type: Negative Pressure Wound Therapy Powered Suction Pump (OMP) · General & Plastic Surgery
Smith and Nephew Medical Limited
K263567 · Decided Nov 6, 2026 · 37 days after receipt
Device type: Negative Pressure Wound Therapy Device For Reduction Of Wound Complications (QFC) · General & Plastic Surgery
- Single Use Optical Fiber510(k)
K262886 · Decided Nov 5, 2026 · 80 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
- BioCharge510(k)
K263682 · Decided Nov 5, 2026 · 29 days after receipt
Device type: Mesh, Surgical, Absorbable, Orthopaedics, Reinforcement Of Tendon (OWW) · General & Plastic Surgery
- Sonovein SystemNew device typeDe Novo
DEN250063 · Decided Nov 4, 2026 · 331 days after receipt
Device type: Product code (SJR) · General & Plastic Surgery
K262500 · Decided Nov 4, 2026 · 107 days after receipt
Device type: Gown, Non-Sterile, Non-Isolation, Intended To Provide Moderate Or High Barrier Protection (QPC) · General & Plastic Surgery
Guangdong Newdermo Biotech Co., Ltd.
K262781 · Decided Nov 4, 2026 · 90 days after receipt
Device type: Light Based Over The Counter Wrinkle Reduction (OHS) · General & Plastic Surgery
K263664 · Decided Nov 3, 2026 · 29 days after receipt
Device type: Absorbable Lung Biopsy Plug (OMT) · General & Plastic Surgery
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 32 | 0 | 0 |
| Jan 24 | 29 | 1 | 0 |
| Feb 24 | 25 | 1 | 0 |
| Mar 24 | 33 | 1 | 0 |
| Apr 24 | 29 | 1 | 1 |
| May 24 | 37 | 0 | 0 |
| Jun 24 | 30 | 0 | 0 |
| Jul 24 | 30 | 2 | 0 |
| Aug 24 | 34 | 0 | 0 |
| Sep 24 | 25 | 0 | 1 |
| Oct 24 | 35 | 2 | 0 |
| Nov 24 | 32 | 0 | 0 |
| Dec 24 | 33 | 0 | 0 |
| Jan 25 | 24 | 0 | 0 |
| Feb 25 | 30 | 0 | 1 |
| Mar 25 | 26 | 0 | 0 |
| Apr 25 | 31 | 0 | 0 |
| May 25 | 38 | 0 | 0 |
| Jun 25 | 35 | 0 | 0 |
| Jul 25 | 29 | 0 | 0 |
| Aug 25 | 24 | 0 | 0 |
| Sep 25 | 30 | 0 | 2 |
| Oct 25 | 49 | 1 | 0 |
| Nov 25 | 29 | 0 | 1 |
| Dec 25 | 34 | 0 | 1 |
| Jan 26 | 23 | 0 | 0 |
| Feb 26 | 26 | 1 | 1 |
| Mar 26 | 35 | 0 | 3 |
| Apr 26 | 24 | 0 | 0 |
| May 26 | 40 | 1 | 2 |
| Jun 26 | 34 | 0 | 3 |
| Jul 26 | 22 | 1 | 1 |
| Aug 26 | 27 | 0 | 0 |
| Sep 26 | 38 | 0 | 0 |
| Oct 26 | 31 | 1 | 0 |
| Nov 26 | 8 | 1 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
- Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring FracturesRecruiting
SI-BONE, Inc.Public (SIBN)
NCT07530497 · 120 participants (planned) · Start Aug 24, 2026 · Primary completion Feb 2028
Device: iFuse TORQ TNT Implant System · For: Fracture; Pelvic; Insufficiency Fractures; Fragility Fracture and 3 more
Sites: Los Angeles, California; Edina, Minnesota; Rochester, Minnesota · 4 sites in all
Artoss Inc.Not on our public-company list
NCT06256458 · 200 participants (planned) · Start Dec 1, 2023 · Primary completion Dec 1, 2026
Device: NanoBone® Bone Graft · For: Fractures, Bone
Sites: Madison, Wisconsin
Jeisys Medical IncNot on our public-company list
NCT07805655 · 60 participants (planned) · Start Sep 15, 2026 · Primary completion Dec 25, 2026
Device: Sequential Radiofrequency Treatment · For: Acne Vulgaris
Sites: Nuevo León, Mexico
Sofwave Medical LTDNot on our public-company list
NCT07723664 · 30 participants (planned) · Start Jul 20, 2026 · Primary completion Jul 15, 2027
Device: SofWave · For: Facial Wrinkles; Jawline Contour; Skin Laxity
Sites: Houston, Texas
- Silica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsPivotal-lookingRecruiting
Cutempa Medical AGNot on our public-company list
NCT07937215 · 280 participants (planned) · Start Aug 20, 2026 · Primary completion Feb 2028
Device: Curi01 · For: Diabetic Foot Disease; Foot Ulcer Due to Type 1 Diabetes Mellitus; Foot Ulcer Due to Type 2 Diabetes Mellitus
Sites: Bad Mergentheim, Germany; Berlin, Germany; Bremerhaven, Germany · 13 sites in all
Aesculap AGNot on our public-company list
NCT05966961 · 2,998 participants (planned) · Start Sep 18, 2023 · Primary completion Aug 2028
Device: Novosyn® in emergency or elective laparotomy or laparoscopic surgery; Polyglactin 910 in emergency or elective laparotomy or laparoscopic surgery · For: Surgical Site Infection
Sites: Bari, Italy; Castel Volturno, Italy; Lavagna, Italy · 11 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
126,787
Received Nov 1, 2025 to Nov 19, 2026. Includes 310 of another or unstated type.
Malfunction reports
72,373
57% of reports
Injury reports
53,884
42% of reports
Death reports
220
0.2% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 4,840 | 3,983 | 13 | 3 |
| Dec 25 | 5,890 | 4,663 | 15 | 3 |
| Jan 26 | 5,191 | 4,165 | 12 | 7 |
| Feb 26 | 5,285 | 4,292 | 12 | 1 |
| Mar 26 | 5,535 | 5,041 | 26 | 1 |
| Apr 26 | 5,808 | 5,120 | 9 | 4 |
| May 26 | 4,928 | 4,750 | 26 | 2 |
| Jun 26 | 5,913 | 4,736 | 33 | 2 |
| Jul 26 | 5,902 | 4,479 | 26 | 20 |
| Aug 26 | 9,189 | 4,449 | 21 | 92 |
| Sep 26 | 8,689 | 4,310 | 8 | 92 |
| Oct 26 | 5,203 | 3,896 | 19 | 83 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.